AMED News and Press, Amedisys Inc From 10/26/22

BATON ROUGE, La., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2022. Three-Month Periods Ended September 30, 2022 and 2021 Net service revenue increased...

BATON ROUGE, La., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the third quarter ended September 30, 2022, after the market closes on October 26, 2022. The Com...

The partnership is the first-of-its-kind in the region and creates a new care at home option for patients, including Recovery Care at Home, Rehabilitation Care at Home, Palliative Care at Home, Primary Care at Home and Home Health LITTLE ROCK, Ark. and NASHVILLE, Tenn., Oct. 11, 202...

BATON ROUGE, La., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice, personal care and high-acuity care company, announced today that Adam Holton will join the Company as Chief People Officer. With more than 20 years of experience, Ho...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Summary Amedysis came in with a flat set of earnings last quarter, with downsides relative to consensus at the top and bottom line. Balance sheet metrics are weakening and the company now claims a large portion of equity value via intangibles and goodwill. We note additional p...

NEW YORK and NASHVILLE, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Mount Sinai Health System and Contessa, the leading comprehensive home-based care provider, announced the extension of their partnership combining Mount Sinai South Nassau’s home health agency into their existing joint ...

Amedisys Inc (AMED) Q2 2022 Earnings Conference Call July 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Chris Gerard - President and Chief Executive Officer Scott Ginn - Executive Vice President and Chief Financial Officer Da...

Amedisys press release ( NASDAQ: AMED ): Q2 Non-GAAP EPS of $1.47 beats by $0.24 . Revenue of $557.89M (-1.1% Y/Y) misses by $25.23M . Updated 2022 Guidance Adjusted net service revenue is anticipated to be in the range of $2.290 billion to $2.310 billion v...

BATON ROUGE, La., July 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2022. Three-Month Periods Ended June 30, 2022 and 2021 Net service revenue decreased $6.3 milli...